Cite
MLA Citation
F. Di Mario et al.. “P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population.” Digestive and liver disease, vol. 49, n.d., pp. e140–e141. http://access.bl.uk/ark:/81055/vdc_100045163095.0x000059